| Zugriffe | |
|---|---|
| Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant | 3 |
| Mai 2024 | Juni 2024 | Juli 2024 | August 2024 | September 2024 | Oktober 2024 | November 2024 | |
|---|---|---|---|---|---|---|---|
| Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant | 0 | 0 | 0 | 0 | 0 | 3 | 0 |
| Zugriffe | |
|---|---|
| CPT Pharmacom Syst Pharma - 2024 - Kim - Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows.pdf | 6 |
